Marinus Pharmaceuticals Inc (MRNS)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

5 RADNOR CORPORATE CENTER SUITE 500 RADNOR, PA 19087

Marinus Pharmaceuticals, Inc. manufactures medical products. The Company offers development and commercialization of medical drugs for the treatment of serious neurological and psychiatric disorders such as epilepsy, post traumatic stress, and fragile-x syndrome.

Data as of 2021-05-08 11:36:26 -0400
Market Cap516.166 Million Shares Outstanding36.633 Million Avg 30-day Volume192.002 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-7.23 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low20.04 / 6.04 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from MRNS instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 1 100.0% 2 (0.12%) 1 (0.06%) 100.0%
Funds Holding: 89 78 14.1% 34 (2.04%) 28 (1.74%) 21.43%
13F shares: 30.966 Million 24.265 Million 27.62% 19.895 Million 14.171 Million 40.39%
% Ownership 86.9969 79.3115 9.69% 55.8955 46.32 20.67%
New Positions: 24 11 118.18% 12 5 140.0%
Increased Positions 37 40 -7.5% 13 16 -18.75%
Closed Positions 13 29 -55.17% 6 13 -53.85%
Reduced Positions 15 22 -31.82% 4 7 -42.86%
Total Calls 518.477 Thousand 1.228 Million -57.79% 124.2 Thousand 823.7 Thousand -84.92%
Total Puts 1.042 Million 867.655 Thousand 20.1% 250.525 Thousand 74.2 Thousand 237.63%
PUT/CALL Ratio 2.01 0.71 183.1% 2.02 0.09 2144.44%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MRNS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MRNS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

4.3 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PFANSTIEL STEVEN CFO

  • Officer
0 2021-04-12 2

NOCHUR SARA

  • Director
33,000 2021-03-22 2

VITULLO NICOLE

  • Director
3,692 2021-03-12 2

SMITH EDWARD F FORMER VP, CFO & TREASURER

  • Officer
13,288 2021-03-09 1

MAYLEBEN TIMOTHY M

  • Director
0 2021-01-15 1

CARRAZANA ENRIQUE J.

  • Director
0 2021-01-15 1

FISCHER SETH H. Z.

  • Director
0 2021-01-15 1

DOUGHERTY MICHAEL R

  • Director
0 2021-01-15 1

BRAUNSTEIN SCOTT CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2021-01-15 1

HULIHAN JOSEPH CHIEF MEDICAL OFFICER

  • Officer
0 2021-01-15 1

EZICKSON ELAN

  • Director
0 2021-01-15 1

MANNING MARTHA E VP GEN COUNSEL AND CORP SEC.

  • Officer
0 2021-01-15 3

AUSTIN CHARLES

  • Director
0 2021-01-15 3

LORIANNE MASUOKA K. CHIEF MEDICAL OFFICER

  • Officer
0 2019-08-21 0

CASHMAN CHRISTOPHER MICHAEL CEO

  • Officer
  • Director
271,423 2019-03-18 0

BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC

BAIN CAPITAL LIFE SCIENCES PARTNERS, LP

BAIN CAPITAL LIFE SCIENCES FUND, L.P.

BCIP LIFE SCIENCES ASSOCIATES, LP

SCHWARTZ JEFFREY LAWRENCE

KOPPEL ADAM

  • 10% Owner
No longer subject to file 2017-12-15 0

SHEPARD JAY

  • Director
0 2017-01-17 0

MEHRA ANAND

SOFINNOVA VENTURE PARTNERS VI L P

SOFINNOVA VENTURE PARTNERS VI GMBH & CO. KG

SOFINNOVA VENTURE AFFILIATES VI LP

SOFINNOVA MANAGEMENT VI, L.L.C.

BUATOIS ERIC

HEALY JAMES

AZAN ALAIN

POWELL MICHAEL

  • 10% Owner
No longer subject to file 2016-10-20 0

CANAAN VII LP

CANAAN PARTNERS VII LLC

  • 10% Owner
No longer subject to file 2016-08-05 0

MEHRA ANAND

  • Director
0 2016-08-03 0

PATRONEVA ALBENA CHIEF MEDICAL OFFICER

  • Officer
0 2016-08-03 0

BLOCH STEPHEN M

  • Director
2,500,948 2015-09-24 0

FARFEL GAIL M CHIEF CLINICAL DEV & REG OFFIC

  • Officer
0 2015-04-21 0

SHAH NIMESH

  • 10% Owner
42,550 2015-01-01 0

GOPKA ANTON

  • Director
0 2014-09-30 0

DOMAIN PARTNERS VI, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

  • Director
  • 10% Owner
2,476,886 2014-08-05 0

DP VI ASSOCIATES, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

  • Director
  • 10% Owner
17,000 2014-08-05 0

DOMAIN ASSOCIATES

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

HALAK BRIAN K

KAMDAR KIM P.

  • Director
  • 10% Owner
42,550 2014-07-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PFANSTIEL STEVEN - Officer CFO

2021-04-13 21:59:19 -0400 2021-04-12 A 220,000 a 220,000 direct

NOCHUR SARA - Director

2021-03-24 16:23:02 -0400 2021-03-22 A 33,000 a 33,000 direct

VITULLO NICOLE - Director

2021-03-16 16:58:52 -0400 2021-03-16 J 2,717 a 3,692 direct -0.5625 -9.75 -7.1875 3.1875 3 -13.4375 24

VITULLO NICOLE - Director by domain associates, llc

2021-03-16 16:58:52 -0400 2021-03-16 J 11,612 d 0 indirect -0.5625 -9.75 -7.1875 3.1875 3 -13.4375 24

VITULLO NICOLE - Director by one palmer square associates vi, llc

2021-03-16 16:58:52 -0400 2021-03-16 J 6,192 d 0 indirect -0.5625 -9.75 -7.1875 3.1875 3 -13.4375 24

VITULLO NICOLE - Director by dp vi associates, l.p.

2021-03-16 16:58:52 -0400 2021-03-15 S 4,250 $15.87 d 0 indirect -0.5625 -9.75 -7.1875 3.1875 3 -13.4375 24

VITULLO NICOLE - Director by domain partners vi, l.p.

2021-03-16 16:58:52 -0400 2021-03-12 J 619,221 d 0 indirect -0.5625 -9.75 -7.1875 3.1875 3 -13.4375 24

VITULLO NICOLE - Director by one palmer square associates vi, llc

2021-03-16 16:58:52 -0400 2021-03-12 J 6,192 a 6,192 indirect -0.5625 -9.75 -7.1875 3.1875 3 -13.4375 24

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
MARINUS PHARMACEUTICALS INC MRNS 2021-05-10 22:15:04 UTC -0.932 0.982 900000
MARINUS PHARMACEUTICALS INC MRNS 2021-05-10 21:45:02 UTC -0.9073 0.9573 900000
MARINUS PHARMACEUTICALS INC MRNS 2021-05-10 21:15:02 UTC -0.9073 0.9573 900000
MARINUS PHARMACEUTICALS INC MRNS 2021-05-10 20:45:03 UTC -0.9638 1.0138 900000
MARINUS PHARMACEUTICALS INC MRNS 2021-05-10 20:15:03 UTC -0.9638 1.0138 900000
MARINUS PHARMACEUTICALS INC MRNS 2021-05-10 19:45:03 UTC -0.9638 1.0138 900000
MARINUS PHARMACEUTICALS INC MRNS 2021-05-10 19:15:03 UTC -0.9638 1.0138 900000
MARINUS PHARMACEUTICALS INC MRNS 2021-05-10 18:45:03 UTC -0.9638 1.0138 900000
MARINUS PHARMACEUTICALS INC MRNS 2021-05-10 18:15:03 UTC -0.9638 1.0138 900000
MARINUS PHARMACEUTICALS INC MRNS 2021-05-10 17:45:02 UTC -0.9638 1.0138 900000
MARINUS PHARMACEUTICALS INC MRNS 2021-05-10 17:15:03 UTC -0.9638 1.0138 900000
MARINUS PHARMACEUTICALS INC MRNS 2021-05-10 16:45:03 UTC -0.9638 1.0138 900000
MARINUS PHARMACEUTICALS INC MRNS 2021-05-10 16:15:03 UTC -0.9638 1.0138 900000
MARINUS PHARMACEUTICALS INC MRNS 2021-05-10 15:45:03 UTC -0.9638 1.0138 850000
MARINUS PHARMACEUTICALS INC MRNS 2021-05-10 15:15:03 UTC -0.9638 1.0138 850000
MARINUS PHARMACEUTICALS INC MRNS 2021-05-10 14:45:04 UTC -0.4955 0.5455 850000
MARINUS PHARMACEUTICALS INC MRNS 2021-05-10 14:15:04 UTC -0.4955 0.5455 850000
MARINUS PHARMACEUTICALS INC MRNS 2021-05-10 13:45:04 UTC -0.4955 0.5455 850000
MARINUS PHARMACEUTICALS INC MRNS 2021-05-10 13:15:03 UTC -0.4955 0.5455 850000
MARINUS PHARMACEUTICALS INC MRNS 2021-05-10 12:45:02 UTC -0.4955 0.5455 850000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AQR Funds- AQR Small Cap Relaxed Constraint Equity Fund MRNS -1779.0 shares, $-2739.66 2019-09-30 N-PORT

Elevate your investments